LIFEAZE LTD
Company number 15501060 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
LIFEAZE LTD - Analysis Report
Company Number: 15501060
Analysis Date: 2025-07-19 12:33 UTC
Financial Health Assessment for LIFEAZE LTD (as at 28 February 2025)
1. Financial Health Score: D
Explanation:
LIFEAZE LTD is a newly incorporated private limited company with its first reported financial year ending February 2025. The company shows a negative net asset position (£-898), meaning its liabilities slightly exceed its current assets. This is a sign of financial strain or initial start-up losses. While the total liabilities and assets are small, the negative equity indicates the company is currently undercapitalized or has accumulated losses. The grade "D" reflects a company in early-stage development but showing symptoms of financial distress that require close monitoring and corrective action.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Cash at Bank | 1,282 | Low but positive cash balance - healthy cash presence. |
| Current Liabilities | 2,180 | Short-term obligations exceeding cash and assets. |
| Net Current Assets | -898 | Working capital deficit, a symptom of liquidity pressure. |
| Net Assets (Shareholders’ Funds) | -898 | Negative equity indicates financial strain or initial losses. |
| Employees | 1 | Micro business, low overheads but limited operational scale. |
- Liquidity: The company’s cash is less than its current liabilities, indicating a risk of difficulty meeting short-term obligations without additional funding or revenue inflows.
- Solvency: Negative net assets reflect that the company’s total liabilities are higher than its assets, a warning sign of potential insolvency if the trend continues.
- Business Scale: With only one employee and a micro-business profile, LIFEAZE LTD is likely in its startup or early growth phase.
3. Diagnosis
LIFEAZE LTD is in the critical early stage of its financial life cycle, facing the typical "start-up symptoms" of negative equity and working capital deficits. The company’s financial position resembles a patient whose vital signs are weak but stable: it has some cash on hand but a small gap between current assets and liabilities causing liquidity stress. The negative net assets could be the result of initial operating losses or start-up costs not yet offset by sales revenues.
The director’s report mentions optimism about sales growth and profitability, which is encouraging. However, the balance sheet shows that the company is currently undercapitalized and potentially vulnerable if anticipated sales growth does not materialize quickly.
4. Recommendations
- Improve Liquidity: Increase cash reserves to cover current liabilities comfortably. This could be through owner investment, loans, or faster collection of receivables.
- Monitor Working Capital Closely: Maintain a tight control on payables and receivables to reduce the working capital deficit and avoid cash flow bottlenecks.
- Enhance Capital Structure: Consider injecting additional equity capital to strengthen the balance sheet and provide a buffer against early losses.
- Focus on Revenue Growth: Accelerate sales efforts, leveraging the director’s sales expertise to improve turnover and profitability.
- Cost Control: Keep overheads minimal given the micro scale, ensuring expenses do not outpace incoming revenues.
- Prepare for Next Filing: Ensure timely filing of accounts and confirmation statements to maintain compliance and avoid penalties, supporting overall corporate health.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.